Alto Mayo Cacao (Theobroma cacao)
Alto Mayo Cacao (Theobroma cacao) is a Peruvian highland-grown cacao variety cultivated in the San Martín region at elevations above 800 meters, where altitude-influenced soil chemistry may reduce cadmium uptake into the bean. Like all Theobroma cacao, it contains methylxanthines (theobromine, caffeine), flavanols (epicatechin, catechin), and cocoa butter composed primarily of stearic, oleic, and palmitic acids, though variety-specific bioactive concentrations remain unquantified in peer-reviewed literature.
Origin & History
Alto Mayo Cacao is a cultivar variant of Theobroma cacao sourced from Peru's Alto Mayo region in provinces like Bagua and Utcubamba, grown at altitudes of 350-2900m with 500-4000mm annual rainfall. The cacao beans undergo standard processing including fermentation, sun-drying, roasting, and grinding into cocoa liquor, powder, or butter.
Historical & Cultural Context
No traditional medicine uses are documented for Alto Mayo Cacao specifically. While Theobroma cacao has ancient Mesoamerican use by civilizations like the Maya, this predates or is unrelated to modern Peruvian Alto Mayo cultivation, which is characterized through contemporary agronomic studies.
Health Benefits
• No clinical health benefits documented - research focuses solely on agronomic traits • Potentially lower cadmium exposure compared to lowland cacao due to altitude effects on soil chemistry • Contains standard cacao components like cocoa butter, though specific bioactive concentrations unquantified • No cardiovascular or metabolic benefits studied for this specific cultivar variant • Evidence quality: None - no human trials or biomedical research available
How It Works
Alto Mayo Cacao contains theobromine, a methylxanthine that inhibits phosphodiesterase enzymes (PDE3, PDE4), elevating intracellular cyclic AMP and producing mild bronchodilatory and cardiovascular effects. Its flavanols, particularly epicatechin, activate endothelial nitric oxide synthase (eNOS) and upregulate Nrf2-mediated antioxidant pathways, potentially improving vascular tone. Higher-altitude cultivation may limit cadmium bioavailability through soil pH and zinc competition at root transporter level (ZIP family transporters), though this mechanism has not been confirmed specifically for Alto Mayo beans.
Scientific Research
No human clinical trials, RCTs, or meta-analyses exist for Alto Mayo Cacao specifically. While general Theobroma cacao studies on cardiovascular health exist (e.g., PMID: 28802278), none evaluate this Peruvian cultivar variant for biomedical outcomes.
Clinical Summary
No clinical trials have been conducted specifically on Alto Mayo Cacao as a distinct variety; available research focuses entirely on its agronomic characteristics, flavor profile, and geographic origin in Peru's San Martín region. General Theobroma cacao research—such as the COSMOS-cocoa trial (n=21,442) and smaller RCTs using 400–900 mg cocoa flavanols daily—demonstrates cardiovascular and cognitive benefits attributable to epicatechin and catechin, but these findings cannot be extrapolated to Alto Mayo without variety-specific phytochemical quantification. Cadmium reduction claims associated with highland growing conditions are supported by soil science literature correlating altitude with lower cadmium bioavailability, but no human exposure studies have compared Alto Mayo versus lowland cacao directly. Overall, the evidence base for Alto Mayo specifically is absent, and any attributed health benefits rely entirely on inference from generic cacao research.
Nutritional Profile
Alto Mayo cacao (Theobroma cacao) from the Alto Mayo region of San Martín, Peru, has not been subjected to comprehensive nutritional profiling distinct from general fine-flavor cacao. Based on standard Theobroma cacao bean composition and regional agronomic data, approximate values per 100 g of dried, fermented beans are as follows: **Macronutrients:** Fat 48–57 g (predominantly cocoa butter composed of ~34% stearic acid, ~34% oleic acid, ~26% palmitic acid, and ~2% linoleic acid), Protein 11–15 g (rich in arginine, leucine, and phenylalanine), Total dietary fiber 9–14 g (mostly insoluble cellulose and hemicellulose), Carbohydrates 10–18 g (including residual sugars ~1–2 g post-fermentation), Moisture 5–7 g. **Minerals:** Magnesium 400–500 mg, Potassium 1,300–1,600 mg, Phosphorus 500–700 mg, Iron 10–15 mg (non-heme, low bioavailability ~2–5% unless consumed with ascorbic acid), Zinc 5–7 mg, Copper 3–4 mg, Manganese 2–4 mg, Calcium 100–160 mg. **Cadmium note:** Alto Mayo beans grown at higher altitudes (800–1,500 m.a.s.l.) may exhibit lower cadmium concentrations (~0.2–0.6 mg/kg) compared to lowland Peruvian cacao (~0.8–2.0+ mg/kg), potentially linked to lower soil Cd availability at altitude, though this is variable by microsite. **Bioactive compounds:** Theobromine 1.0–2.5 g (primary methylxanthine, ~10× caffeine concentration; bioavailability high, >90% absorbed), Caffeine 0.1–0.3 g, Total polyphenols 4–8 g gallic acid equivalents (highly variable with fermentation degree — fermentation reduces polyphenol content by 40–70%), Epicatechin 1.0–4.0 mg/g (the dominant flavan-3-ol monomer; bioavailability ~20–30%, enhanced by food matrix fats), Catechin 0.2–1.0 mg/g, Procyanidins (B-type oligomers, dimers through decamers) 2–6 mg/g total (bioavailability decreases sharply with polymerization degree; dimers ~10%, larger oligomers <1%), Anthocyanins (cyanidin-3-arabinoside and cyanidin-3-galactoside) 0.1–0.5 mg/g in unfermented beans (largely degraded during fermentation). **Vitamins:** Niacin (B3) 1.5–2.5 mg, Folate (B9) ~30–40 µg, Pantothenic acid (B5) ~0.5–1.0 mg, Vitamin E (predominantly γ-tocopherol) 0.5–1.5 mg; fat-soluble vitamin bioavailability is enhanced by the high cocoa butter content. **Other bioactives:** Phenylethylamine trace amounts (~0.5–1.0 mg), Anandamide trace (<0.05 mg), Serotonin precursor tryptophan ~200–300 mg. **Regional specificity:** Fine-flavor cacao from Alto Mayo (often Criollo or Trinitario-type genetic backgrounds) may have higher aromatic precursor concentrations (free amino acids and reducing sugars post-fermentation) contributing to flavor but no published data quantify differential bioactive concentrations specific to this origin versus other Peruvian or global cacao. All values are estimates extrapolated from general T. cacao literature and should be interpreted cautiously in the absence of origin-specific analytical data.
Preparation & Dosage
No clinically studied dosage ranges available for Alto Mayo Cacao in any form (extract, powder, or standardized preparations). No human trials have established therapeutic doses or standardization parameters. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
No synergistic ingredients identified due to lack of biomedical research
Safety & Interactions
Alto Mayo Cacao carries the same safety profile as standard Theobroma cacao: theobromine can cause tachycardia, insomnia, and gastrointestinal upset at high intakes, particularly in individuals sensitive to methylxanthines. Cacao flavanols may potentiate antiplatelet effects of aspirin, clopidogrel, and anticoagulants like warfarin, increasing bleeding risk, and may modestly lower blood pressure, requiring caution with antihypertensive medications. Cadmium accumulation remains a concern with all cacao products from high-cadmium regions; while Alto Mayo's altitude may reduce this risk, consumers with kidney disease should exercise caution until cadmium content is independently verified. Pregnant and breastfeeding individuals should limit cacao intake due to caffeine and theobromine content, and individuals with chocolate allergies or migraines triggered by phenylethylamine should avoid cacao-containing products.
